Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.
Giordano A, Liu Y, Armeson K, Park Y, Ridinger M, Erlander M, Reuben J, Britten C, Kappler C, Yeh E, Ethier S.
Giordano A, et al. Among authors: park y.
PLoS One. 2019 Nov 21;14(11):e0224420. doi: 10.1371/journal.pone.0224420. eCollection 2019.
PLoS One. 2019.
PMID: 31751384
Free PMC article.